All News

falls.jpg (keep)

Falls with Knee Osteoarthritis

d Jack Cush, MD

A study of adults aged 45-85 yrs shows that knee osteoarthritis (OA) is an independent risk factor for falls, suggesting a greater need for awareness and prevention.

Read Article
NSAIDs.pills_.caps_.jpg

NSAID Prescribing Decreasing

d Jack Cush, MD

Multinational metanalyses of data between 1989 and 2022 shows that NSAID prescriptions have decreased over time, and differs according to geographical locations.

Read Article
gcascalp_0.jpg

How Age of Onset Affects Giant Cell Arteritis

d MedPage Today

Giant cell arteritis (GCA) has a different phenotype when diagnosed late in life compared with earlier onset, a large Italian cohort study indicated.

Read Article
DXA1.jpg (keep)

FRAX Tool is Suboptimal in Predicting Osteoporosis Fracture Risk in Younger Post-menopausal Women

d EurekAlert!

The commonly used Fracture Risk Assessment Tool (FRAX), which includes self-identified race and ethnicity information, and the Osteoporosis Self-Assessment Tool (OST), which does not, had suboptimal performance in determining major osteoporotic fracture risk across racial/ethnic categories in you

Read Article
acupuncture.jpg

The Burden of Chronic Pain in US Adults (2019-2020)

d Jack Cush, MD

Analysis of National Health Interview Survey data shows that the incidence of chronic pain in the USA is high compared with other chronic diseases.

Read Article
ICYMI: Spondyloarthritis Innovations https://t.co/N7AHcRIwcG https://t.co/eAgdiGTawz

Links:

Dr. John Cush RheumNow ( View Tweet)
Therapeutic Plasma Exchange: Core Curriculum 2023 - Comprehensive, full read overview from American Journal of Kidney diseases & the National Kidney Foundation https://t.co/rmwwj5gol3 https://t.co/XFRZyD6hV4

Links:

Dr. John Cush RheumNow ( View Tweet)
View our infographic from the #LupusEducatorsNetwork and discover how you can apply the concept of #DiseaseModification in #Lupus and #LupusNephritis to help treat patients in your clinical practice #SponsoredbyGSKUSMA https://t.co/fzspfwarK4 https://t.co/jXNte7f0sY

Links:

Dr. John Cush RheumNow ( View Tweet)
Watch: RNL23 Vasculitis Faculty Panel Q&A RheumNow Live 2023: Robert Spiera, MD, Hospital for Special Surgery Anisha Dua, MD, MPH, Northwestern University, Feinberg School of Medicine Carol Langford, MD, MHS, FACP https://t.co/4ddqt2tAQ8 https://t.co/KIPp3rePpp

Links:

Dr. John Cush RheumNow ( View Tweet)
SURPASS: SEC vs ADA for axSpA Outcome: %pts with no radiographic progression Not benefit- Secukinumab not better than adalimumab Though negative study, in all groups the progression was very low (<1 mSASS) - both interventions did well! #RNL2023 https://t.co/xlw4nzrwpm https://t.co/dhhLMFQnhI

Links:

Dr. John Cush RheumNow ( View Tweet)
Watch: GPA Treatment Choices https://t.co/MU6gZrgYDr https://t.co/lT1jI9jGGS

Links:

Dr. John Cush RheumNow ( View Tweet)
Colchicine does not work in Hand OA. Danish trial of 100 HOA pts (age 71 yrs) given placebo or COL 0.5 mg bid x 12wk. Finger pain improved –13·9 mm w/ colchicine vs –13·5 mm w/ PBO (NS). More adverse events w/ Colchicine (72% vs 44%) https://t.co/rfANCLcZii https://t.co/OFuMGZSvhm

Links:

Dr. John Cush RheumNow ( View Tweet)
Risk factors for radiographic progression: Men ♂️ Smoking 🚬 Active inflammation🔥 Blue collar workers 💪 HLA-B27+ 💉 Pre-existing syndesmophyte 🩻 Atul Deodhar at #RNL2023 @RheumNow https://t.co/FcwrDtOG6I https://t.co/AvRpPrg1UK

Links:

Dr. John Cush RheumNow ( View Tweet)
BIOBADASER registry of 3,366 RA/AS/PsA pts on 1,2 bDMARDs saw Remission-related Biologic D/C by 80 pts (2.4%). D/C Factors: short Dz duration (OR: 0.95), no csDMARDs (OR:0.56), shorter use prior bDMARD. Less D/C w/ smoking & ACPA+ https://t.co/iUdU9iI4AZ https://t.co/TknRW6pnJR

Links:

Dr. John Cush RheumNow ( View Tweet)
INBUILD study was an all cause ILD nintedanib RCT (n=663). Subanalysis of 89 RA-ILD pts showed FVC decline (@ 52 wks) was −82.6 mL/yr on NIN vs −199.3 mL/yr on PBO (p=.037). NIN diarrhea in 62%; & AE discontinuation in 24% https://t.co/nWuGx6wjB2 https://t.co/LVwy1Z5TL3

Links:

Dr. John Cush RheumNow ( View Tweet)
Tuesday Night Rheumatology: POD 7: Spondyloarthritis Innovations https://t.co/eDZlgdeWGr

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Atul Deodhar on AxSpA - 5-40% of nr-axSpA progress to r-axSpA over 2-10 years - is non-radiographic axSpA a misnomer? @RheumNow #RNL2023 https://t.co/HaavCnplO0 https://t.co/3jQaxVfFBH

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Deodhar reminds us of his "3,4,5 rule" for diagnosing AS. *Erosions in 3 or more SIJ quadrants *BME in 4 or more SIJ quadrants *Fat lesions in 5 of more SIJ quadrants #RNL2023 @RheumNow https://t.co/6iAXKfZvEY https://t.co/kxqbiXVd2w

Links:

Dr. John Cush RheumNow ( View Tweet)
#RNL2023 @RheumNow Atul Deodhar: Prevalence of AS is increasing! Is it truly more? Or likely better recognized and diagnosed, as well as increased recognition of nr-AxSpa https://t.co/HnzRrKko75 https://t.co/CBbvFIbRoi

Links:

Dr. John Cush RheumNow ( View Tweet)
Allergic Drug-Induced Arthritis Dr. Jack Cush reviews the news and journal reports from this past week on https://t.co/iRqfkFu52z. This week we delve into some odd associations, repeat drug warnings and the consequences of antirheumatic therapies. https://t.co/lRBaXMAgz6 https://t.co/37gIHniIEi

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×